Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities-Reference-Cited by-同舟云学术

Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities

Published:2016-07 Issue:1 Volume:194 Page:77-83
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Ho Jennifer E.^ORCID,Gao Wei,Levy Daniel,Santhanakrishnan Rajalakshmi,Araki Tetsuro,Rosas Ivan O.,Hatabu Hiroto,Latourelle Jeanne C.,Nishino Mizuki,Dupuis Josée,Washko George R.,O’Connor George T.,Hunninghake Gary M.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference39 articles.

1. The regulation of inflammation by galectin-3

2. Galectin-3 regulates myofibroblast activation and hepatic fibrosis

3. Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis

4. Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

5. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1);Cancer Chemotherapy and Pharmacology;2024-08-21

2. Clusters of multidimensional exercise response patterns and estimated heart failure risk in the Framingham Heart Study;ESC Heart Failure;2024-06-28

3. Emerging Roles of Galectin-3 in Pulmonary Diseases;Lung;2024-06-08

4. Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction;Chinese Medical Journal Pulmonary and Critical Care Medicine;2024-06

5. Interstitial Lung Abnormalities (ILA) and Pulmonary Fibrosis;Current Pulmonology Reports;2024-04-02